Parathyroid pathology hyperparathyroidism and parathyroid tumors

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 11, 2010, Pages 1639-1644

  Carlson, Diane ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOMA; HUMAN; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; PARATHYROID GLAND; PARATHYROID TUMOR; PATHOLOGY;

CARCINOMA; HUMANS; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; PARATHYROID GLANDS; PARATHYROID NEOPLASMS;

EID: 78249289133     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Shaha AR, Shah JP. Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer. 1999;86(3):378-380.
2. DeLellis RA. Tumors of the Parathyroid Gland. Washington, DC: Armed Forces Institute of Pathology: 1993. Atlas of Tumor Pathology. 3rd series, fascicle 6.
3. Gomes EM, Nunes RC, Lacativa PG, et al. Ectopic and extranumerary parathyroid glands location in patients with hyperparathyroidism secondary to end stage renal disease. Acta Cir Bras. 2007;22(2):105-109.
4. Seethala RR, Virji MA, Ogilvie JB. Pathology of the parathyroid glands. In: Leon Barnes, ed. Surgical Pathology of the Head and Neck. Vol III. New York, NY: Informa Health Care; 2009:1429-1472.
5. Heffess CS. Embryology, anatomy, and histology. In: Wenig B. Atlas of Head and Neck Pathology. 2nd ed. 2008. China: Saunders Elsevier; 2008:1012-1028.
6. Uno N, Tominaga Y, Matsuoka S, et al. Incidence of parathyroid glands located in thymus in patients with renal hyperparathyroidism. World J Surg. 2008;32(11):2516-2519.
7. DeLellis RA, Williams ED. Tumors of the thyroid and parathyroid. DeLellis RA, Lloyd RV, Heitz PU, Eng C, eds. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004: 49-56, 228-229. World Health Organization Classification of Tumours. vol 8.
8. Rosai J. Parathyroid glands. In: Rosai J. Rosai and Ackerman's Surgical Pathology. 9th ed. New York, NY: Mosby; 2004:595-619.
9. Judson BL, Shaha AR. Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidism. J Nucl Med. 2008;49(11):1813-1818.
10. Seethala RR, Ogilvie JB, Carty SE, Barnes EL, Yim JH. Parathyroid lipoadenomas and lipohyperplasias: clinicopathologic correlations. Am J Surg Pathol. 2008; 32(12):1854-1867.
11. Stojadinovic A, Hoos A, Nissan A, et al. Parathyroid neoplasms: clinical histopathological, and tissue microarray-based molecular analysis. Hum Pathol. 2003;34(1):54-64.
12. Okamoto T, Iihara M, Obara T, Tsukada T. Parathyroid carcinoma: etiology, diagnosis, and treatment. World J Surgery. 2009;33(11):2343-2354.
13. Sinha S, Sinha A, McPherson GA. Synchronous sporadic carcinoma and primary hyperplasia of the parathyroid glands: a case report and review of the literature. Int J Surg Pathol. 2006;14(4):336-339.
14. Erickson LA, Jin L, Papotti M, Lloyd RV. Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases. Am J Surg Pathol. 2002;26(3):344-399.
15. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. Chicago, IL: Springer. 2010.
16. Hadar T, Sheyero J, Yaniv E, Ram E, Shyili I, Koren R. Experssion of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue. Pathol Oncol Res. 2005;11(1):45-49.
17. Naccarato AG, Marocci C, Miccoli P, et al. Bcl-2, p53, and MIB-1 expression in normal and neoplastic parathyroid tissues. J Endocrinol Invest. 1998;21(3):136-141.
18. Szende B, Farid P, Vegso G, Perner F, Kopper L. Apoptosis and p53, Bcl-2, and Bax gene expression in parathyroid glands of patients with hyperparathyroidism. Pathol Oncol Res. 2004;10(2):98-103.
19. Wang W, Johansson H, Kyasnicka T, Farnebo LO, Grimelius L. Detection of apoptotic cells and expression of Ki-67, Bcl-2, p53 oncoproteins in human parathyroid adenoma. APMIS. 1996;104(11):789-796.
20. Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ. Familial isolated hyperparathyroidism is rarely caused by germline mutation sin HRPT2, the gene for the hyperparathyroid-jaw tumor syndrome. J Clin Endocrinol Metab. 2004;89(1):96-102. 1644